ArticleBMC cardiovascular disorders2025
Different impact of female gender on the outcome of catheter ablation between paroxysmal and persistent atrial fibrillation.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Sex-based disparities in postoperative outcomes after catheter ablation for atrial fibrillation: a systematic review and meta-analysis of propensity-matched studies.BMC cardiovascular disorders · 2026Pooled it
- Women's cardiovascular health in 2025:Saudi medical journal · 2026Review
- Non-alcoholic fatty liver disease as a predictor of atrial fibrillation recurrence following ablation: a retrospective study.Cardiovascular diagnosis and therapy · 2025Article
- Arrhythmia-Induced Cardiomyopathy in Atrial Fibrillation: Pathogenesis, Diagnosis, and Treatment.Life (Basel, Switzerland) · 2025Review
- Hormonal Atrial Fibrillation: Pathophysiological Mechanisms That Trigger and Sustain the Arrhythmic Circuits.Biomedicines · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundThe impacts of gender on the outcome of atrial fibrillation (AF) ablation have been studied previously with contradictory results. Given the heterogeneities in clinical and pathophysiological characteristics between paroxysmal and persistent AF, gender impacts on post-ablation recurrence might differ depending on the type of AF.
aimsThis study aimed to investigate the differing impacts of female gender on catheter ablation outcomes between paroxysmal and persistent AF. METHODS AND
resultsA total of 857 patients (537 (62.7%) males and 320 (37.3%) females) undergoing de novo catheter ablation of AF were included in this retrospective study. Gender differences in ablation outcomes for different types of AF were compared. Of all patients, 476 were diagnosed with paroxysmal AF (PAF) and 381 with persistent AF (PeAF). Compared to male patients, female patients were older (64.0 ± 8.9 vs. 59.5 ± 10.7 years, P < 0.001), and more likely to have PAF (64.4% vs. 50.3%, P < 0.001). During a median follow-up of 53 [37-72] months, the total atrial tachyarrhythmia (ATa) recurrence rate after a single procedure was 35.4%, with no difference between male and female patients (34.5% vs. 36.9%, P = 0.473). For PAF, the recurrence was slightly higher in males than in females (37.4% vs. 30.1%, P = 0.096). On the contrary, for PeAF, females had a significantly higher risk of recurrence than males (49.1% vs. 31.5%, P = 0.001). The multivariate Cox regression analysis showed that female gender was an independent predictor of post-ablation recurrence only in PeAF (HR = 1.686; 95% CI 1.196-2.377, P = 0.003).
conclusionsThe female gender had different impacts on the outcome of catheter ablation between PAF and PeAF. The ATa recurrence was significantly higher in females than males only for PeAF. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.